Stockscreener 앱 받기
21.64
3.67%
-0.86
시간 외 거래:
21.66
0.02
+0.09%
Fresenius Medical Care Ag Adr 주식(FMS)의 최신 뉴스
Research in Brief: Online hemodiafiltration and medium cut-off dialyzers - Fresenius Medical Care
Fresenius Medical Care stock (DE0005785802): Dividend vote and guidance shape the 2026 setup - AD HOC NEWS
Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care - Fresenius Medical Care
Fresenius Medical Care stock (DE0005785802): New focus on dialysis demand and margin discipline - AD HOC NEWS
Fresenius Medical Care reappoints CFO Martin Fischer until 2031 - Investing.com
Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer - Morningstar
Fresenius Medical Care stock (DE0005785802): earnings update and strategy focus - AD HOC NEWS
Fresenius Medical Care stock (DE0005785802): dialysis specialist in focus after latest quarterly upd - AD HOC NEWS
Fresenius Medical Care stock (DE0005785802): New dialysis trends keep the company in focus - AD HOC NEWS
Ready4 Ci-Ca: Innovation in clinical education - Fresenius Medical Care
Fresenius Medical Care: Shares Look Attractive, Despite Market Uncertainty Around Margin Trajectory - Morningstar
Fresenius Medical Care AG (FMS) Stock Price, Trades & News - GuruFocus
Fresenius SE & Co. KGaA stock (DE0005785604): Global healthcare giant with US dialysis exposure - AD HOC NEWS
Fresenius Medical Care stock (DE0005785802): Dialysis giant faces headwinds and opportunities in 202 - AD HOC NEWS
Fresenius Medical Care Q1 2026 slides: margin expansion amid revenue pressures - Investing.com Australia
Fresenius Medical Care Q1 2026 slides: margin expansion amid revenue pressures By Investing.com - Investing.com South Africa
Fresenius Medical Care's Margin Improvement Looks Just Paused in 2026, Not Over - Morningstar
Earnings call transcript: Fresenius Medical Care Q1 2026 beats EPS expectations - Investing.com
Fresenius Medical Care Q1 shares fall on U.S. treatment slowdown - Investing.com
Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speed - Fresenius Medical Care
Fresenius Medical Care stock (DE0005785802): Is chronic kidney disease demand strong enough to unloc - AD HOC NEWS
Fresenius Medical Care stock (DE0005785802): Why Google Discover changes matter more now - AD HOC NEWS
Fresenius Medical Care stock (DE0005785802): Is U.S. dialysis dominance still the key growth engine? - AD HOC NEWS
Fresenius Medical Care stock (DE0005785802): Why U.S. dialysis demand now drives the real value test - AD HOC NEWS
Fresenius Medical Care stock (DE0005785802): Is U.S. dialysis dominance still the key growth lever? - AD HOC NEWS
Research in Brief: Immunosuppressive therapies in kidney transplant recipients - Fresenius Medical Care
Fresenius Medical Care Sets May 21, 2026 AGM With Dividend and New Buyback Mandate on Agenda - TipRanks
Fresenius Medical Care (NYSE: FMS) plans €1.49 dividend and renews 10% buyback mandate - Stock Titan
Fresenius Medical Care stock: What you should know now before buying - AD HOC NEWS
Supporting living donors through the Circle of Excellence - Fresenius Medical Care
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now - Zacks Investment Research
Fresenius Medical Care stock advances FME Reignite strategy with Interwell Health investment amid st - AD HOC NEWS
10 New 5-Star Stocks This Week - Morningstar
Fresenius Medical Care publishes its Annual Report 2025: The power of care - Fresenius Medical Care
Research round-up: Innovation that moves kidney care forward - Fresenius Medical Care
Advancing kidney care: Introducing high-volume hemodiafiltration to the U.S. - Fresenius Medical Care
Fresenius Medical Care Faces a Transition Year in 2026 on New Product Launch Activities - Morningstar
Fresenius Medical Care marks World Kidney Day and National Kidney Month - Fresenius Medical Care
Fresenius Medical Care's 2030 Ambition: Navigating a Pivotal Transition () - aktiencheck.de
Fresenius Medical Care: An Undervalued Stock to Buy Now and Hold for the Long Term - Morningstar
5 Undervalued Stocks That Crushed Q4 Earnings - Morningstar
FMS Stock Rises as Q4 Earnings & Sales Beat Estimates, Margins Expand - Finviz
Research in brief: Nocturnal home hemodialysis - Fresenius Medical Care
Fresenius Medical Care ADR earnings beat by $1.11, revenue topped estimates - Investing.com Australia
Fresenius Medical Care published Report on Form 20-F for fiscal year 2025 - Fresenius Medical Care
Fresenius Medical Care Q4 2025 slides: margin surge, flat 2026 outlook - Investing.com
Earnings call transcript: Fresenius Medical Care Q4 2025 beats EPS expectations - Investing.com
Fresenius Medical Care falls nearly 7% despite earnings beat - Investing.com South Africa
Fresenius Medical Care falls 7% after 2026 flat growth outlook and cost update - Investing.com
Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band - Fresenius Medical Care
Uncovering Potential: Fresenius Medical Care's Earnings Preview - Sahm
Fresenius Can't Knock Out 401(k) Forfeiture Suit - Law360
Research in Brief: Hemodiafiltration and hospitalization burden in ESKD - Fresenius Medical Care
FedEx Upgraded, Costco Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
0.42%
0.33%
자본화:
|
볼륨(24시간):